FINWIRES · TerminalLIVE
FINWIRES

Flutter Q2 Likely to Show Some Top-Line Noise, Wedbush Says

By

Flutter Entertainment (FLUT) is expected to show favorable underlying trends amid some top-line noise in Q2, Wedbush said in a Thursday preview note. The results are due Aug. 5.

The report said the company is likely to deliver above-consensus handle, but slightly below-consensus revenue and EBITDA.

While sports results are likely a bigger revenue drag than expected, US handle is expected to return to Q2 growth and online sports betting share trends will likely show modest sequential improvement, and into the start of Q3, the note said.

"Despite our reduced estimates, we do not see risk the FLUT will

lower its already conservative guidance," the report said.

The report said positive detail and incremental disclosure on FanDuel Predicts and its market-making initiatives during the World Cup could help investors gain some confidence.

Wedbush kept its outperform rating with a $138 price target.

Price: $102.16, Change: $-5.62, Percent Change: -5.22%

Related Articles

Wire

Houlihan Lokey Fiscal Q1 Adjusted Earnings, Revenue Fall; Shares Drop After Hours

Houlihan Lokey (HLI) reported fiscal Q1 adjusted earnings late Wednesday of $1.35 per diluted share, down from $2.14 a year earlier.Analysts polled by FactSet expected $1.64.Revenue in the three months ended June 30 fell to $511 million from $605 million a year earlier.Analysts expected $602.4 million.Houlihan Lokey shares fell 6.6% in after-hours trading.

$HLI
Wire

Four Corners Property Trust Q2 AFFO, Revenue Rise

Four Corners Property Trust (FCPT) reported Q2 adjusted funds from operations late Wednesday of $0.45 per diluted share, up from $0.44 a year earlier.Analysts polled by FactSet expected $0.45.Revenue in the quarter ended June 30 rose to $78.4 million from $72.8 million a year earlier.Four analysts expected $79 million.The company's shares rose 2% in after-hours trading.

$FCPT
Wire

Corcept Therapeutics Q2 Earnings, Revenue Rise; Shares Jump After Hours

Corcept Therapeutics (CORT) reported Q2 earnings late Wednesday of $0.36 per diluted share, up from $0.29 a year earlier.Analysts polled by FactSet expected $0.02.Revenue for the three months ended June 30 rose to $256.1 million from $194.4 million a year earlier.Analysts expected $221.1 million.The company boosted full-year revenue guidance to $1.1 billion to $1.2 billion from the prior forecast of $950 million to $1.05 billion.Analysts project $999.5 million.Corcept shares jumped 18% in after-hours trading.

$CORT